The broad, long term objectives of this research are to use NMR and quantum chemical methods to learn more about protein structure and function and to apply these methods to protein structure prediction and refinement, including the topic of enzyme/inhibitor or drug/target interactions. The first specific aim is to compute NMR shielding surfaces for side-chains in amino acids; to calibrate these theoretical results versus experimental shielding tensors and orientations, and to incorporate these results into a Web Chemical Shift calculator, as well as the CNS program, for use in protein and peptide structure determination. Second, we will use combined multinuclear (1-H, 2-H, 17-O) NMR and quantum chemical methods to investigate hydrogen bonding and electrostatics in peptides and proteins. Third, we will use NMR, x-ray diffraction and quantum chemical methods to probe enzyme-inhibitor interactions, focussing on the bisphosphonate class of drugs which inhibit the enzymes farnesyl pyrophosphate and geranylgeranyl pyrophosphate synthase, and which have potent bone anti-resorptive, anti-cancer and anti-parasitic activity. The fourth and final specific aim is to use NMR and quantum chemical methods to develop improved approaches for quantitative structure-activity relationship studies (quantum QSAR applications).

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM050694-12
Application #
6992747
Study Section
Molecular and Cellular Biophysics Study Section (BBCA)
Program Officer
Wehrle, Janna P
Project Start
1995-01-01
Project End
2007-12-31
Budget Start
2006-01-01
Budget End
2007-12-31
Support Year
12
Fiscal Year
2006
Total Cost
$272,022
Indirect Cost
Name
University of Illinois Urbana-Champaign
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
041544081
City
Champaign
State
IL
Country
United States
Zip Code
61820
Guo, Rey-Ting; Cao, Rong; Liang, Po-Huang et al. (2007) Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases. Proc Natl Acad Sci U S A 104:10022-7
Yardley, Vanessa; Khan, Anis A; Martin, Michael B et al. (2002) In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii. Antimicrob Agents Chemother 46:929-31